Alembic Limited
Valuation (98/100) does the heavy lifting; financial trend (31/100) is the drag.
Buy zoneStocksWizard rates Alembic Limited a Buy, scoring 68/100 on our blended model. At ₹91.13 it trades below our blended DCF and relative-multiples fair value of ₹119.48, about 31% upside to that estimate — we read it as undervalued by 31%. On 7.1x trailing earnings it sits cheaper than the Real Estate median of about 27.5x. The price is about 19% below its 52-week high of ₹111.95 and 29% above the low of ₹70.9. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 8 of 13 investability checks, with durability 77, valuation 95 and momentum 47 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹95.58.
1-year price
EOD · 2026-07-3152-week range
-18.60% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Buy68Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 13.3%
- Pass: Low debt (D/E < 0.5): 0.00x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: -0%
- Fail: Earnings growing: -2%
- Pass: Net margin ≥ 10%: 132.2%
- Pass: Current ratio > 1.5: 1.95
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 10.44
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter72.2%
- Institutions0.9%
- Public & other26.9%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Healthy profit margin (132.2%).
- Financially solid — Altman Z 10.44.
Opportunities
- Trading in our value buy zone versus sector peers.
- Trades ~31% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
About Alembic Limited
Alembic Limited operates across two business segments in India and internationally. Through its API segment, the company manufactures active pharmaceutical ingredients, while its Real Estate segment develops residential and commercial properties, offers project management and marketing consultancy services, and leases commercial properties.
Alembic Limited — frequently asked questions
Is Alembic Limited a buy, hold or sell?
StocksWizard currently rates Alembic Limited (ALEMBICLTD) a Buy, based on a blended score of 68/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Alembic Limited's fair value?
Our blended DCF and relative-valuation model estimates Alembic Limited's fair value at about ₹119.48, versus a current price of ₹91.13 — roughly 31% upside. On that basis the stock looks undervalued by 31%.
Is Alembic Limited financially healthy?
Alembic Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Alembic Limited's share price performed?
Alembic Limited is roughly flat over three months, and last traded at ₹91.13. Past performance doesn't predict future returns.
More in Real Estate
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.